Stock analysis · Bull Rankings model

CL analysis

Colgate-Palmolive CompanyHousehold & Personal Products. Scored on the same transparent model behind the daily rankings.

CL
Colgate-Palmolive Company · Household & Personal Products
FCF$3.9bB
Rev+5.2%C+
D/E
P/E35.9xC
PEG1.75C+
56.7Score
$91.08$72.6B
1Y Target$98.95Analyst consensus · 20 analysts
5Y Target$144.87Compound horizon
10Y Target$214.91Long-dated conviction
FCF$3.9bTTM
B
FCF $3.9b — solid, comfortably covers operations and capital return
Rev+5.2%TTM YoY
C+
Revenue +5.2% — steady but below market-beating range
D/E
D/E data unavailable — neutral default
P/E35.9x
C
P/E 35.9 — expensive vs Consumer Defensive peers (≈90th pctile)
PEG1.75
C+
PEG 1.75 — modest premium; above fair value

Forward price target — the 1-year figure is the analyst consensus where the stock is covered; the 5- and 10-year figures compound our earnings estimate from there. The DCF below is a separate cross-check on intrinsic value (what it's worth today), not another target.

Quality-growth score · 56.7
Quality89.0
Growth67.7
Value30.3
Why this score
  • Durable high returns
Entry · Margin of safety
52-week rangeNear 52-week high
8% off the 12-month high
vs DCF fair value20% aboveest. fair value ~$76
What the price assumes: free cash flow compounding at ~9% a year for the next decade — vs the ~6% a year our model projects from current growth and analyst estimates.
Quality signals · context only
Gross profitability76% · Agross profit ÷ total assets (Novy-Marx)
ROIC27.0% · Areturn on invested capital — not score-weighted

Model-generatedGenerated by the Bull Rankings model from this company's reported fundamentals, and checked against the figures shown above.

Why now
Household & Personal Products · market cap $72.6b. 8% off the 52-week high of $99.33. 20 sell-side analysts rate this a Buy with a mean 1-yr target of $98.95 (implying +9% upside).
Moat
FCF converts 189% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined. $72.6b market cap gives the company enough scale to absorb fixed costs that subscale competitors can't, without yet being so large that growth has to come from acquisition.
Risk
Trailing P/E 36x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.
Horizon
1-3 yr $98.95 (20-analyst consensus) — fundamentals + valuation re-rating. 5 yr $144.87 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $214.91 if current growth sustains into durable earnings power.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.

CL vs the Top Picks average

PillarCLBook avgDiff
Quality0.890.84+0.05
Growth0.680.84-0.16
Value0.300.78-0.48

Averaged across the 30 names in today's Top Picks (mean score 81.5). A name can beat these averages and still be absent from the book — it also applies concentration limits.

Trend
+2.4 over 45 daily scores
From 54.3 (Jun 22) → 56.7 (now)

One point per daily model run. The range autoscales, so a flat-looking line can still hide 1–2 point moves — read the From → To values for the actual range.

Analyst estimate revisions

30-day change+1.4%
90-day change+1.7%
Forward EPS estimate$4.11

Over the last 90 days, what analysts expect CL to earn is drifting higher (+1.7%). The estimate is derived from price and forward P/E captured at the same instant, so a moving share price does not move this number — only a changed forecast does.

A rising estimate means expectations are improving, not that the price has failed to keep up — and estimates get cut as readily as they get raised. It is not part of the Bull Rankings score. Biggest movers across the market →

Shares to buy
21
Position size
$1,913
3.8% of portfolio
Stop price
$68.31
25% below $91.08
$ at risk if stopped
$478.17
budget $500.00 · 1% of portfolio

Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.

Colgate-Palmolive Company (CL): score, valuation & FAQ

Colgate-Palmolive Company (CL) is a Household & Personal Products company that scores 56.7 out of 100 on the Bull Rankings quality-growth model — a middling reading. The score blends three pillars — quality (durable returns, healthy margins, low leverage), growth (revenue and earnings), and value (valuation versus sector peers) — into one number, refreshed daily; it is a screen, not a buy recommendation.

On valuation, CL sits about 20% above our discounted-cash-flow fair value — the current price implies roughly 9% annual free-cash-flow growth over the next decade.

Is CL a good stock to buy?

Bull Rankings scores CL 56.7 out of 100 on its quality-growth model, which is a middling reading. A score is a quantitative screen of Colgate-Palmolive Company's fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.

Why does CL score 56.7 on Bull Rankings?

The quality-growth score blends three pillars — quality (returns on capital, margins, leverage, earnings quality), growth (revenue and earnings expansion), and value (valuation versus sector peers). CL grades middle-of-pack across the strip. Each pillar is graded against sector-aware thresholds, then combined into the single 0–100 score.

Is CL overvalued or undervalued?

Based on $91.08, CL sits about 20% above our discounted-cash-flow fair value — the current price implies roughly 9% annual free-cash-flow growth over the next decade. It trades at a 35.9x P/E (graded C). Discounted-cash-flow estimates are sensitive to growth and discount-rate assumptions, so treat this as a cross-check, not a price target.

What are the main risks of investing in CL?

Trailing P/E 36x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.

New to these metrics? The guides explain free cash flow, how the score works, and more in the learn hub — or run another name through the screener.

Bull Rankings is an automated fundamentals screen for research and education. It is not investment advice, and nothing here is a recommendation to buy or sell any security. Do your own research and consider consulting a licensed financial advisor.

More Household & Personal Products stocks by score

All Consumer Defensive rankings →

Analyze another ticker →